James T Koerber

18PUBLICATIONS
113CO-AUTHORS
Molecular targetsAllergyBiologically active moleculesMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity.

|Apr 09, 2026
Complete inhibition of β-tryptase by tetramer dissociation and active site allostery due to a single antibody residue.

Henry R Maun, Caleigh M Azumaya, Benjamin T Walters

|Mar 25, 2026
A modular platform for Sterically Masked Activated Cytokines (SMACks).

Travis J Morgenstern, Naruhisa Ota, Zhonghua Lin

|Oct 01, 2025
A Fit-for-purpose Strategy for Clinical Immunogenicity Assessment of Multivalent Bispecific Antibodies.

Zhaojun Yin, Bob Y Liu, Ben Ordonia

|May 28, 2025
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.

Naruhisa Ota, Christopher W Davies, Jing Kang

|Dec 01, 2023
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.

Dawei Sun, Yonglian Sun, Eric Janezic

Pageof 3

Frequent Collaborators

4 joint publications

Christopher W Davies

3 joint publications

Naruhisa Ota

3 joint publications

Jian Payandeh

3 joint publications

Robert A Lazarus